Glenmark Pharmaceuticals and Canadian biotech firm SaNOtize Research and Development Corp on Monday announced an exclusive long term strategic partnership to manufacture, market and distribute nitric oxide nasal spray (NONS) for Covid-19 treatment in India and other Asian markets. The other Asian market include Singapore, Malaysia, Hong Kong, Taiwan, Nepal, Brunei, Cambodia, Laos, Myanmar, Sri Lanka, Timor-Leste and Vietnam. In […]
Read Time : 1 Minutes
Glenmark Pharmaceuticals receives ANDA approval for Amphetamine Sulfate Tablets USP, 5 mg, 10 mg
Glenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Amphetamine Sulfate Tablets USP, 5 mg and 10 mg, the generic version of Evekeo 1 Tablets, 5 mg and 10 mg, of Arbor Pharmaceuticals, LLC. According to IQVIATM sales data for the 12 month period ending November 2020, the […]
Read Time : 3 Minutes
Glenmark begins phase 3 clinical trials of favipiravir
Glenmark Pharmaceuticals Limited has started the process of conducting phase 3 clinical trials of Favipiravir among Coronavirus disease (Covid-19) patients in India to test the safety and efficacy of the antiviral drug, the company said on Tuesday. According to Glenmark executives familiar with the development, who didn’t want to be […]